
Vascular: AVS Pulse CTO Robert Chisena on Intravascular Lithotripsy and the Future of Calcium Treatment
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Calcified arteries remain one of the toughest challenges in cardiology and peripheral vascular care. Robert Chisena, CTO and co-founder of AVS Pulse Technologies, explains how their intravascular lithotripsy platform uses pulsatile CO₂ energy to fracture calcium safely and effectively.
We cover how AVS Pulse differentiates from competitors, the “smart” IVL feedback system, and why this space has become one of the hottest in medtech after multibillion-dollar acquisitions.
Episode Breakdown
00:00 – Why calcified arterial disease is such a challenge
01:22 – Meet Robert Chisena, CTO and co-founder of AVS Pulse Technologies
02:01 – How calcium buildup blocks blood flow and leads to serious outcomes
03:07 – Why existing technologies struggle with calcium treatment
04:42 – AVS Pulse origins at the University of Michigan
05:34 – Finding the “chinks in the armor” of calcium
06:27 – How pulsatile CO₂ energy fractures calcium
07:38 – The water hammer effect explained
08:37 – Comparing AVS Pulse to existing lithotripsy devices
09:47 – Differentiators: low profile, flexibility, energy efficiency
11:14 – 5000 pulses vs rationing with other catheters
13:12 – Clinical studies show fast, safe outcomes in complex lesions
13:45 – First “smart” IVL device with intra-procedural feedback
14:54 – Regulatory pathway and pivotal trials in peripheral and coronary indications
17:02 – Promising first-in-human PAD I study results
19:07 – How energy delivery reduces dissections compared to other methods
21:24 – What happens to calcium once fractured
22:01 – Positioning IVL as a prep tool for stenting
23:32 – Differentiating IVL from thrombectomy and other treatments
23:38 – Funding raised and milestones ahead
24:45 – Timeline for commercial launch and next clinical trials
25:02 – Upcoming conferences: TCT and VIVA presentations
26:08 – Why the market is heating up and where AVS Pulse fits in
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#Medtech #Leadership #ScottHuennekens #Healthcare #MedicalDevices #Entrepreneurship